Background
Pulmonary hemorrhage is a common complication in preterm infants, especially in very low-and extremely low-birth-weight infants, and has high morbidity and mortality rates. Although some studies have analyzed the epidemiological incidence of pulmonary hemorrhage and related factors, there are discrepancies between the results of these studies due to differences in study populations and study designs. Therefore, we conducted a meta-analysis of the factors affecting pulmonary hemorrhage to provide a reference for early clinical recognition and prevention of pulmonary hemorrhage.
Methods
Systematic searches of the PubMed, Embase, Cochrane Library and other databases were performed to extract the results of logistic regression analyses of case-control or cohort studies related to the factors affecting pulmonary hemorrhage in very-low and extremely-low-birth-weight infants. The data were analyzed using RevMan 5.3 software.
Results
A total of 13 studies were included and 11 influencing factors were screened through quantitative integration. All factors were statistically significant except for hypothermia: birth weight (OR=0.75, 95% CI 0.59-0.97, P=0.03, I2=95%), coagulation disorders (OR=4, 95% CI 1.79-8.93, P<0.01, I2=66%), patent ductus arteriosus (OR=3.52, 95% CI 1.71-7.27, P<0.01, I2=80%), mechanical ventilation (OR=2.94, 95% CI 1.94-4.45, P<0.01, I2=0%), aneaemia (OR=5.15, 95% CI 2.92-9.07, P<0.01, I2=43%), 5-min Apgar score (OR=1.6, 95% CI 1.21-2.11, P<0.01, I2=46%), early-onset sepsis (OR=2.71, 95% CI 1.62-4.53, P<0.01, I2=0%), antenatal steroids (OR=0.39, 95% CI 0.21-0.73, P<0.01, I2=25%), preterm birth (OR=1.99, 95% CI 1.34-2.97, P<0.01, I2=47%), and blood product transfusion (OR=6.16, 95% CI 2.15-17.69, P<0.01, I2=0%).
Conclusion
This study revealed the factors affecting pulmonary hemorrhage in very-low and extremely-low-birth-weight infants, and the results of the meta-analysis will be supplemented by a standardized cohort study based on this study.
Trial registration
PROSPERO (CRD42023465025)